News

Welcome to the future of translational and early clinical development.
Scientifically driven with access to multiple centres of excellence.
Customisable full service underpinned by the highest quality clinical conduct.
World-leading patient and healthy volunteer recruitment capabilities.
Delivering the best value solution for early clinical development.
In January 2018 CRO’s Phase I unit moved from Campus Virchow-Klinikum (CVK) to Campus Mitte at Charité – Universitätsmedizin Berlin. Located at the very heart of Charité’s historic campus, the new facilities underwent extensive modernisation and therefore offer ideal conditions for the conduct of early clinical trials.
The new unit provides access to an increased capacity of 70 in-patient beds and can even be reconfigured to house up to 90 beds. Considering the previous capacity of 30 beds and additional upgrades to the unit this move allows us to extend the scope of services we can offer.
These additional upgrades include an integrated GMP area which is under construction at the moment. The close proximity to institutes and experts at Charité Campus Mitte on the other hand offers possibilities for the establishment of new cooperations as well as the development of existing ones. In this context CRO can access all available resources at Charité – Universitätsmedizin Berlin such as 24-hr emergency services and state-of-the-art diagnostic as well as imaging capabilities.
All in all this relocation marks another important milestone in the continued and sustainable growth of Charité Research Organisation as a dedicated CRO for clinical research from FTIH to PoC.
Get in touch with our Business Development Team to find out how Charité Research Organisation can deliver optimal value for your early clinical research projects and help you reach Proof of Concept faster.
Studienberatung
Patienten und Probanden erreichen uns unter (030) 450 539 210.
Please feel free to discuss your early clinical trials with us. Your message will be received attentively by our business development team. We come back to you with feedback from our clinicians and project management experts....
Some more text